SS
Salim Sadiq Shaikh
About Salim Sadiq Shaikh
Data last updated:
Salim Sadiq Shaikh is a Whole-Time Director at Symbio Generrics India Private Limited (since 2011), Director at Vpl Chemicals Private Limited (since 2022) and Director at Wiserise Ventures Private Limited (since 2022), and holds 6 more current directorships. The companies operate in Pharma, Internet and Business Outsourcing. The 6 current companies with reported revenue have a combined latest revenue of ₹511 Cr; the largest is Symbio Generrics India Private Limited at ₹435 Cr (FY 2025). Earlier, Salim Sadiq Shaikh was a Director at Launchmydrug Technologies Private Limited (from 2018) and Director at Actinic Pharmaceuticals Private Limited (from 2013) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Symbio Generrics India Private Limited U74990KA2011PTC184231 | Whole-Time Director | 30 May 2011 | 2011 | ₹435 Cr (FY 2025) | Active |
 Vpl Chemicals Private Limited U24100KA1999PTC025992 | Director | 30 Jun 2022 | 1999 | ₹57.32 Cr (FY 2025) | Active |
 Wiserise Ventures Private Limited U74999MH2022PTC393951 | Director | 22 Nov 2022 | 2022 | ₹10.43 Cr (FY 2025) | Active |
| Copernicium Pharmaceuticals Private Limited U24230KA2013PTC072419 | Director | 10 Dec 2013 | 2013 | ₹6.15 Cr (FY 2024) | Active |
 Blumen Biovitals Healthkare Private Limited U74999MH2017PTC299002 | Director | 24 Aug 2017 | 2017 | ₹1.57 Cr (FY 2024) | Active |
 Sequent Penems Private Limited U24233KA2010PTC053548 | Director | 25 Apr 2024 | 2010 | ₹70.9 Lakh (FY 2025) | Active |
| Anveta Therapeutics Private Limited U72100MH2026PTC473365 | Director | 11 Jul 2026 | 2026 | Active | |
| Strider Lifesciences Private Limited U72200MH2023PTC409557 | Director | 29 Aug 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Launchmydrug Technologies Private Limited U72900MH2017PTC291283 | Director | 27 Feb 2018 | 2017 | Strike Off | |
| Actinic Pharmaceuticals Private Limited U74900MH2013PTC245814 | Director | 17 Jul 2013 | 2013 | Strike Off | |
| Plainview Pharmaceuticals Private Limited U74999MH2016PTC281980 | Director | 02 Jun 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Salim Sadiq Shaikh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Suresh Puranik | Symbio Generrics India Private Limited | Ceo | |
| Akash Suresh Puranik | 06775891 | Symbio Generrics India Private Limited , Vpl Chemicals Private Limited and 3 more | Managing Director |
| Deepak Komaregowda | 03298261 | Symbio Generrics India Private Limited | Nominee Director |
| Kannan Natraj Sharma | 00408118 | Symbio Generrics India Private Limited | Director |
| Madhu Bhumalingam Talla | 09115066 | Wiserise Ventures Private Limited | Director |
| Saad Abdul Hasan Shaikh | 09436744 | Blumen Biovitals Healthkare Private Limited | Director |
| Coumara Radja | 10298985 | Anveta Therapeutics Private Limited , Strider Lifesciences Private Limited | Director |
| Vanchi Vijay Rajan | 10892512 | Anveta Therapeutics Private Limited , Strider Lifesciences Private Limited | Director |
| Abhijit Govindrao Kale | 03398414 | Symbio Natural Products Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Salim Sadiq Shaikh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salim Sadiq Shaikh
Salim Sadiq Shaikh currently holds 9 directorships: Symbio Generrics India Private Limited (Whole-Time Director, since 30 May 2011, revenue ₹435 Cr (FY 2025)); Vpl Chemicals Private Limited (Director, since 30 Jun 2022, revenue ₹57.32 Cr (FY 2025)); Wiserise Ventures Private Limited (Director, since 22 Nov 2022, revenue ₹10.43 Cr (FY 2025)); Copernicium Pharmaceuticals Private Limited (Director, since 10 Dec 2013, revenue ₹6.15 Cr (FY 2024)); Blumen Biovitals Healthkare Private Limited (Director, since 24 Aug 2017, revenue ₹1.57 Cr (FY 2024)); and 4 more.
Salim Sadiq Shaikh was first appointed on 30 May 2011 as Whole-Time Director at Symbio Generrics India Private Limited. The most recent appointment on record is 11 Jul 2026 at Anveta Therapeutics Private Limited.
The 6 current companies of Salim Sadiq Shaikh that report revenue have a combined latest revenue of ₹511 Cr: Symbio Generrics India Private Limited ₹435 Cr (FY 2025); Vpl Chemicals Private Limited ₹57.32 Cr (FY 2025); Wiserise Ventures Private Limited ₹10.43 Cr (FY 2025); Copernicium Pharmaceuticals Private Limited ₹6.15 Cr (FY 2024); Blumen Biovitals Healthkare Private Limited ₹1.57 Cr (FY 2024); and 1 more.
Salim Sadiq Shaikh held 3 earlier board appointments: Launchmydrug Technologies Private Limited (Director, from 27 Feb 2018); Actinic Pharmaceuticals Private Limited (Director, from 17 Jul 2013); Plainview Pharmaceuticals Private Limited (Director, from 02 Jun 2016).
The current boards of Salim Sadiq Shaikh's companies include Akash Suresh Puranik (Symbio Generrics India Private Limited), Akash Suresh Puranik (Symbio Generrics India Private Limited), Deepak Komaregowda (Symbio Generrics India Private Limited), Kannan Natraj Sharma (Symbio Generrics India Private Limited), Madhu Bhumalingam Talla (Wiserise Ventures Private Limited), Saad Abdul Hasan Shaikh (Blumen Biovitals Healthkare Private Limited), among others.